Tag: Alzheimer

  • COMFORTage

    COMFORTage

    January 1, 2024 @ 8:00 am – December 31, 2027 @ 5:00 pm CET

    (PROJECT)

    Grupo Antena. “COMFORTage.” Accessed 14.08.2025. https://comfortage.eu.

    COMFORTage is a four-year project funded through the European Unión´s Horizon Europe Programme involving 39 organisations from 12 countries. Funded by the European Union (Grant Nº 101137301) and supported by Innovative UK (Grant Nº 10103541) . Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.

    Fostering Personalized solutions for prevention of dementia and frailty

    COMFORTAGE is a joint effort of medical experts, social scientists and humanists, technical experts, Digital Innovation Hubs (DIHs) and Living Labs (LLs) to establish a pan European framework for Community-based, Integrated and People-Centric prevention, monitoring and progression managing solutions for dementia and frailty.

    COMFORTage will developed 13 pilots at 8 EU members states.  The main objective is to supply relevant subjects data on Scientific Technology Options Assessment  (SToA) referred to dementia and frailty detection and intervention and deploy, validate and evaluate the models and tools in real life new clinical scenarios (Beta Solution Treated and Overaged-BSToA).

    COMFORTage Virtualized AI-Based Healthcare Platform (VHP)

    The project will create a first of a kind Virtualized AI-Based Healthcare Platform (VHP) that will centralize access to project’s AI resources for risk factor analysis, early diagnosis and personalized decision making for age-related mental and physical diseases and disorders.

    Partners

    COMFORTage strives to establish a pan-European framework for community-based prevention and intervention strategies to facilitate effective lifestyle changes thought the synergies of our Consortium and other stakeholders. Our consortium is compose by:

    • 8 Research Institutions/Universities
    • 11 Healthcare Organizations & Actors
    • 12 Industry and SME partners
    • 4 Social Multipliers and Associations
    • 4 SSH and Legal Organizations
    Visit the project website

    UNIVERSITY OF PIRAEUS RESEARCH CENTER

    View Organizer Website

  • EBRAINS: A Research Infrastructure to Advance Neuroscience and Brain Health

    EBRAINS: A Research Infrastructure to Advance Neuroscience and Brain Health

    September 1, 2022 @ 8:00 am – December 31, 2026 @ 5:00 pm CEST

    (PROJECT)

    EBRAINS. “EBRAINS.” Accessed 13.08.2025. https://www.ebrains.eu.

    EBRAINS is an international non-profit association (AISBL), headquartered in Brussels, Belgium. It is made up of 8 Full Members and 35 Associate Members. The Research Infrastructure is organised around a central hub that coordinates a pan-European network of services delivered through National Nodes. EBRAINS is governed by three bodies, the General Assembly, the Governing Board and the Management Board. A National Node Board gathers Node representatives. EBRAINS also has two Advisory Committees, the Science and Technology one and the Ethics and Society one which will soon be instated. EBRAINS is funded by the Horizon Europe Framework Programme.

    A state-of-the-art ecosystem for neuroscience

    EBRAINS is on a mission to revolutionise how neuroscience is conducted. The digital ecosystem that we provide enables advances in brain research that translate to innovations in neuroscience, healthcare and technology.

    Towards a European Brain Partnership to accelerate scientific, technological, and societal needs.

    EBRAINS’ ambition is to enable breakthroughs in different areas of brain science. We are proud to be part of several game-changing projects and initiatives, in which we join forces with leading institutions to achieve tangible results and outcomes. If you’re interested in working with us on specific projects, different possibilities exist. Don’t hesitate to contact us for more information.

    EBRAINS is organised around a central hub that coordinates a pan-European network of services that are delivered through national nodes.

    Visit the project website
  • AI-Mind: Artificial Intelligence for Dementia Prevention

    AI-Mind: Artificial Intelligence for Dementia Prevention

    March 1, 2021 @ 8:00 am – February 28, 2026 @ 5:00 pm CET

    (PROJECT)

    Accelopment Schweiz AG. “AI-Mind”. Accessed 13.08.2025. https://www.ai-mind.eu.

    This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 964220. This website reflects only the author’s view and the Commission is not responsible for any use that may be made of the information it contains.

    What is the challenge?

    There are over 50 million people worldwide living with dementia and by 2030 this number is expected to reach 82 million.

    The ageing brain becomes vulnerable to decline and keeping independency in daily life can become a challenge for the elderly. People with Mild Cognitive Impairment (MCI), an intermediate condition between normal brain ageing and dementia, may develop dementia in the future.

    There is an urgent need for early risk assessment and intervention. Current practices with time-consuming patient investigations focus on late symptoms management  due to a lack of diagnostic tools. This causes numerous implications in terms of familial, medical and care costs.

    With AI-Mind we aim to reduce the disease’s burden by developing novel, AI-based tools to support healthcare professionals in their diagnosis and offering timely interventions to patients.

    At the heart of AI-Mind is our research study, that

    Takes place in Norway, Finland, Italy and Spain and will involve 1,000 participants. 

    Helps to develop and validate artificial intelligence (AI) based tools to predict who is likely to develop dementia.

    The AI-Mind project aims to ease the burden of dementia by creating innovative, AI-driven tools that assist healthcare professionals in predicting dementia risks in patients affected by mild cognitive impairment (MCI). Most dementia treatments focus on managing symptoms once they appear, leaving little room for early prevention. AI-Mind seeks to transform this process by replacing complex and inefficient screening methods with advanced, automated tools powered by AI. These tools will address the critical need for early and precise diagnosis, allowing doctors to identify patients at high risk of developing dementia with greater confidence.

    Oslo University Hospital

    View Organizer Website

    Visit the project website
en_USEnglish
nb_NONorwegian en_USEnglish